Laëtitia Furhmann

9PUBLICATIONS
59CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 12, 2025
Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Nicolas M Viart, Anne-Laure Renault, Séverine Eon-Marchais

|Jun 13, 2022
Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression.

Joanna Cyrta, Camille Benoist, Julien Masliah-Planchon

|May 20, 2021
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.

Catalina Lodillinsky, Laetitia Fuhrmann, Marie Irondelle

|May 16, 2020
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma.

Wei-Wei Shen, Ivan Bièche, Laetitia Fuhrmann

|May 15, 2020
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma.

Jean-Christophe Tille, André F Vieira, Caroline Saint-Martin

Pageof 2